Due to its widespread impact across various developed countries and cultures, cancer has been the focus of an ever-increasing number of studies worldwide.
What makes these studies difficult, however, is the complicated nature of how cells become cancerous and/or malignant, and further is the overwhelming amount of diversity of the kinds of diseases that all fall under the umbrella of “cancer.”
Scientists have made headway in studying the various genetic mutations that occur in cancer cells which make them behave so differently and adversely to healthy cells.
This article highlights the scope for developing therapeutics with new innovative, alternative approaches. The current trillion dollars pharmaceutical industry is in peril where the current drug development pipeline is slow, inefficient and incapable of being extended to multi-combination drug therapies as well as minimally focused on prevention. The complex modeling of diseases and biological functions has been limited because of the inability to integrate large scale molecular pathways.
Watch this Video to understand how recent advances provide breakthrough technology for doing scalable modeling of complex molecular systems to dramatically accelerate drug discovery and development.